【欧盟】评估一种葡聚糖1,4-α-葡萄糖苷酶的安全性
The food enzyme glucan 1,4-α-glucosidase (4-α-d-glucan glucohydrolase, EC 3.2.1.3) is produced with the genetically modified Aspergillus niger strain NZYM-BR by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and its DNA. The food enzyme is intended to be used in starch processing for the production of glucose syrups and distilled alcohol. Since residual amounts of total organic solids (TOS) are removed by the purification steps applied during the production of glucose syrups and by distillation, dietary exposure estimation was considered not necessary. Genotoxicity tests did not raise a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 1,135 mg TOS/kg body weight (bw) per day, the highest dose tested. Similarity of the amino acid sequence of the food enzyme to those of known allergens was searched for and two matches were found. The Panel considered that under the intended conditions of use (other than distilled alcohol production) the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood for this to occur is considered to be low. based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
文章来源:食品伙伴网
- 关于发布团体标准《预包装食品生产食品安全管理要求》的公告 2020-04-01
- 《中国营养学会 膳食纤维专家共识》 正式发布 2022-01-10
- 韩国将对12种健康功能食品的功能性原料实施再评估 2020-02-18
- 膳食纤维在食品领域中应用及其市场前景分析 2020-09-24
- 美国拟扩大螺旋藻提取物的使用范围 2020-05-14